Open Access<p>Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization</p>
Author(s) -
Saito Kobayashi,
Kazuto Tajiri,
Aiko Murayama,
Toshiki Entani,
Yuka Futsukaichi,
Kohei Nagata,
Kosuke Takahashi,
Ichiro Yasuda
Publication year - 2020
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s273929
Subject(s) - medicine , hepatocellular carcinoma , transcatheter arterial chemoembolization , refractory (planetary science) , gastroenterology , liver function , lipiodol , adverse effect , arterial embolization , embolization , urology , surgery , physics , astrobiology
To evaluate the potential of drug-eluting bead (DEB)-transcatheter arterial chemoembolization (TACE) as a treatment option for patients with refractory to conventional lipiodol-based TACE (c-TACE) especially with decreased liver function.